Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
NMR in Biomedicine is Scopus-indexed (Q1, CiteScore 5.1), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 0952-3480Verify ISSN ↗1099-1492Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: About US$3,640 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 88 / 361 | 75th | Q1 |
| Spectroscopy | 34 / 81 | 58th | Q2 |
| Molecular Medicine | 102 / 179 | 43rd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1988–present, best quartile Q1, CiteScore 5.1.
NMR in Biomedicine is Q1 in Radiology, Nuclear Medicine and Imaging (rank 88 of 361), Q2 in Spectroscopy (rank 34 of 81) and Q3 in Molecular Medicine (rank 102 of 179), by CiteScore 2025.
NMR in Biomedicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.1, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.822, quartile Q1, with an H-index of 140.
The publisher lists an article processing charge of about US$3,640 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
NMR in Biomedicine is published by John Wiley and Sons Ltd. Its print ISSN is 0952-3480 and its online ISSN is 1099-1492.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
NMR in Biomedicine has an h-index of 161 and a 2-year mean of 2.39 citations per paper (OpenAlex). Its Scopus CiteScore is 5.1, quartile Q1. On 2-year citations it ranks #85 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
NMR in Biomedicine published 250 papers in 2025; its busiest recent year was 2020 with 258. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from United States (27.1%), China (12%) and France (8.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.